Genovis AB (Sweden) Insiders
| GENO Stock | SEK 26.45 1.40 5.03% |
Genovis AB employs about 37 people. The company is managed by 7 executives with a total tenure of roughly 87 years, averaging almost 12.0 years of service per executive, having 5.29 employees per reported executive. Breaking down Genovis AB's management performance can provide insight into the firm performance.
| Susanne Ahlberg Insider G Counsel |
| BA BA Insider Pres Inc |
Genovis |
Genovis AB Management Team Effectiveness
The company has return on total asset (ROA) of 0.1453 % which means that it generated a profit of $0.1453 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3659 %, meaning that it generated $0.3659 on every $100 dollars invested by stockholders. Genovis AB's management efficiency ratios could be used to measure how well Genovis AB manages its routine affairs as well as how well it operates its assets and liabilities.Genovis AB Workforce Comparison
Genovis AB is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 3,274. Genovis AB claims roughly 37.0 in number of employees contributing just under 2% to stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.34 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26. Genovis AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Genovis AB Price Series Summation is a cross summation of Genovis AB price series and its benchmark/peer.
Genovis AB Notable Stakeholders
A Genovis AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Genovis AB often face trade-offs trying to please all of them. Genovis AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Genovis AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Susanne Ahlberg | G Counsel | Profile | |
| BA BA | Pres Inc | Profile | |
| Magnus Langberg | Group Officer | Profile | |
| Maria Edholm | Controller | Profile | |
| Fredrik Olsson | Pres CEO | Profile | |
| Linda Andersson | VP Production | Profile | |
| Rikke Rytter | VP Marketing | Profile |
About Genovis AB Management Performance
The success or failure of an entity such as Genovis AB often depends on how effective the management is. Genovis AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genovis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genovis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Genovis AB develops, produces, and sells tools for developing new medications and diagnostics for customers in the medical device and pharmaceutical industries. Genovis AB was founded in 1999 and is based in Lund, Sweden. Genovis AB operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 20 people.
Please note, the imprecision that can be found in Genovis AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genovis AB. Check Genovis AB's Beneish M Score to see the likelihood of Genovis AB's management manipulating its earnings.
Genovis AB Workforce Analysis
Traditionally, organizations such as Genovis AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Genovis AB within its industry.Genovis AB Manpower Efficiency
Return on Genovis AB Manpower
| Revenue Per Employee | 2.5M | |
| Revenue Per Executive | 13.3M | |
| Net Income Per Employee | 669.7K | |
| Net Income Per Executive | 3.5M |
Additional Tools for Genovis Stock Analysis
When running Genovis AB's price analysis, check to measure Genovis AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovis AB is operating at the current time. Most of Genovis AB's value examination focuses on studying past and present price action to predict the probability of Genovis AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovis AB's price. Additionally, you may evaluate how the addition of Genovis AB to your portfolios can decrease your overall portfolio volatility.